Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Fascia Iliaca Block for Acute Hip Fractures
NCT03588689Phase 4Completed
- Sponsor
- University of Saskatchewan
- Start
- May 2018
- Primary completion
- Mar 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine in hip fracture, sponsored by University of Saskatchewan. Started May 2018; status: completed.
02
Drugs
ropivacaine
03
Conditions
hip fracture
Beyond the preview
Go deeper on NCT03588689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03588689.